The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
Raf: A Strategic Target for Therapeutic Development Against Cancer
Abstract
The mitogen-activated protein kinase (MAPK) signaling pathway plays a critical role in transmitting proliferative signals generated by cell surface receptors and cytoplasmic signaling elements to the nucleus. Several important signaling elements of the MAPK pathway, particularly Ras and Raf, are encoded by oncogenes, and as such, their structures and functions can be modified, rendering them constitutively active. Because the MAPK pathway is dysregulated in a notable proportion of human malignancies, many of its aberrant and critical components represent strategic targets for therapeutic development against cancer. Raf, which is an essential serine/threonine kinase constituent of the MAPK pathway and a downstream effector of the central signal transduction mediator Ras, is activated in a wide range of human malignancies by aberrant signaling upstream of the protein (eg, growth factor receptors and mutant Ras) and activating mutations of the protein itself, both of which confer a proliferative advantage. Three isoforms of Raf have been identified, and therapeutics targeting Raf, including small-molecule inhibitors and antisense oligodeoxyribonucleotides (ASON), are undergoing clinical evaluation. The outcomes of these investigations may have far-reaching implications in the management of many types of human cancer. This review outlines the structure and diverse functions of Raf, the rationale for targeting Raf as a therapeutic strategy against cancer, and the present status of various therapeutic approaches including ASONs and small molecules, particularly sorafenib (BAY 43-9006).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
The protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Wilhelm, S. M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1443 · Cited by 4,017
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Wan, P. T. C., Garnett, M. J., Roe, S. M., Lee, S., Niculescu-Duvaz, D., Good, V. M., Project, C. G., Jones, C. M., Marshall, C. J., Springer, C. J., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00215-6 · Cited by 2,808
Mitogen-activated protein kinase pathways
Robinson, M. J., & Cobb, M. H. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80061-0 · Cited by 2,474
Mammalian Ras interacts directly with the serine/threonine kinase raf
Vojtek, A. B., Hollenberg, S. M., & Cooper, J. A. (1993) · Cell · doi:10.1016/0092-8674(93)90307-c · Cited by 1,941
Proteins regulating Ras and its relatives
Boguski, M. S., & McCormick, F. (1993) · Nature · doi:10.1038/366643a0 · Cited by 1,901
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
High frequency of BRAF mutations in nevi
Pollock, P. M., Harper, U. L., Hansen, K. S., Yudt, L. M., Stark, M., Robbins, C. M., Moses, T. Y., Hostetter, G., Wagner, U., Kakareka, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1054 · Cited by 1,730
Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers
Schaeffer, H. J., & Weber, M. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2435 · Cited by 1,600
The EGFR family and its ligands in human cancer
Yarden, Y. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00230-1 · Cited by 1,587
Independent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms
Dérijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Science · doi:10.1126/science.7839144 · Cited by 1,555
Kimura, E. T., Nikiforova, M. N., Zhu, Z., Knauf, J. A., Nikiforov, Y. E., & Fagin, J. A. (2003) · PubMed · Cited by 1,510
Phosphorylation of c-jun mediated by MAP kinases
Pulverer, B. J., Kyriakis, J. M., Avruch, J., Nikolakaki, E., & Woodgett, J. R. (1991) · Nature · doi:10.1038/353670a0 · Cited by 1,468
Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions
Kölch, W. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510289 · Cited by 1,441
Raf-1 activates MAP kinase-kinase
Kyriakis, J. M., App, H., Zhang, X.-F., Banerjee, P., Brautigan, D. L., Rapp, U. R., & Avruch, J. (1992) · Nature · doi:10.1038/358417a0 · Cited by 1,283
Protein kinase Cα activates RAF-1 by direct phosphorylation
Kolch, W., Heidecker, G., Kochs, G., Hummel, R., Vahidi, H., Mischak, H., Finkenzeller, G., Marmé, D., & Rapp, U. R. (1993) · Nature · doi:10.1038/364249a0 · Cited by 1,277
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224
Increasing complexity of Ras signaling
Campbell, S. L., Khosravi-Far, R., Rossman, K. L., Clark, G. J., & Der, C. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202174 · Cited by 1,079
Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)
Zimmermann, S., & Moelling, K. (1999) · Science · doi:10.1126/science.286.5445.1741 · Cited by 1,078
Hancock, J. F., Paterson, H., & Marshall, C. J. (1990) · Cell · doi:10.1016/0092-8674(90)90294-o · Cited by 1,059
BRAF and RAS mutations in human lung cancer and melanoma.
Brose, M. S., Volpe, P., Feldman, M. D., Kumar, M. S., Rishi, I., Gerrero, R. M., Einhorn, E., Herlyn, M., Minna, J. D., Nicholson, A. G., et al. (2002) · PubMed · Cited by 1,048
cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway
Vossler, M. R., Yao, H., York, R. D., Pan, M.-G., Rim, C. S., & Stork, P. J. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80184-1 · Cited by 1,046
Nikiforova, M. N., Kimura, E. T., Gandhi, M., Biddinger, P. W., Knauf, J. A., Basolo, F., Zhu, Z., Giannini, R., Salvatore, G., Fusco, A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030838 · Cited by 1,042
Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane
Leevers, S. J., Paterson, H. F., & Marshall, C. J. (1994) · Nature · doi:10.1038/369411a0 · Cited by 1,011
Activation of Raf as a Result of Recruitment to the Plasma Membrane
Stokoe, D., Macdonald, S. G., Cadwallader, K., Symons, M., & Hancock, J. F. (1994) · Science · doi:10.1126/science.7811320 · Cited by 976
Inhibition by cAMP of Ras-Dependent Activation of Raf
Cook, S. J., & McCormick, F. (1993) · Science · doi:10.1126/science.7694367 · Cited by 922
BRAF Mutation in Papillary Thyroid Carcinoma
Cohen, Y., Xing, M., Mambo, E., Guo, Z., Wu, G., Trink, B., Beller, U., Westra, W. H., Ladenson, P. W., & Sidransky, D. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.8.625 · Cited by 922
The Primary Structure of MEK, a Protein Kinase that Phosphorylates the ERK Gene Product
Crews, C. M., Alessandrini, A., & Erikson, R. L. (1992) · Science · doi:10.1126/science.1411546 · Cited by 913
K- and N-Ras Are Geranylgeranylated in Cells Treated with Farnesyl Protein Transferase Inhibitors
Whyte, D. B., Kirschmeier, P., Hockenberry, T. N., Nunez-Oliva, I., James, L., Catino, J. J., Bishop, W. R., & Pai, J.-K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14459 · Cited by 884
Rap1 mediates sustained MAP kinase activation induced by nerve growth factor
York, R. D., Yao, H., Dillon, T., Ellig, C. L., Eckert, S. P., McCleskey, E. W., & Stork, P. J. S. (1998) · Nature · doi:10.1038/33451 · Cited by 859
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1
Zhang, X.-F., Settleman, J., Kyriakis, J., Takeuchi-Suzuki, E., Elledge, S. J., Marshall, M. S., Bruder, J. T., Rapp, U. R., & Avruch, J. (1993) · Nature · doi:10.1038/364308a0 · Cited by 858
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
Singer, G., Oldt, R., Cohen, Y., Wang, B. G., Sidransky, D., Kurman, R. J., & Shih, I.-M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.484 · Cited by 854
Activation of the MAP kinase pathway by the protein kinase raf
Howe, L. R., Leevers, S. J., Gómez, N., Nakielny, S., Cohen, P., & Marshall, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90361-f · Cited by 801
Smeal, T., Binetruy, B., Mercola, D. A., Birrer, M., & Karin, M. (1991) · Nature · doi:10.1038/354494a0 · Cited by 789
Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria
Wang, H.-G., Rapp, U. R., & Reed, J. C. (1996) · Cell · doi:10.1016/s0092-8674(00)81383-5 · Cited by 766
Activation of Mitogen-Activated Protein Kinase Kinase by v-Raf in NIH 3T3 Cells and in Vitro
Dent, P., Haser, W., Haystead, T. A. J., Vincent, L. A., Roberts, T. M., & Sturgill, T. W. (1992) · Science · doi:10.1126/science.1326789 · Cited by 668
Bagrodia, S., Dérijard, B., Davis, R. J., & Cerione, R. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.27995 · Cited by 635
The complexity of Raf-1 regulation
Morrison, D. K., & Cutler, R. E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80060-9 · Cited by 635
Rap1 signalling: adhering to new models
Bos, J. L., de Rooij, J., & Reedquist, K. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073073 · Cited by 626
Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain
Binétruy, B., Smeal, T., & Karin, M. (1991) · Nature · doi:10.1038/351122a0 · Cited by 598
Increasing Complexity of the Ras Signaling Pathway
Vojtek, A. B., & Der, C. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.19925 · Cited by 579
Kato, K., Cox, A. D., Hisaka, M. M., Graham, S. M., Buss, J. E., & Der, C. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6403 · Cited by 540
Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development
Rowinsky, E. K., Windle, J. J., & Von Hoff, D. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3631 · Cited by 537
Self-citationHSP90 as a new therapeutic target for cancer therapy: the story unfolds
Maloney, A., & Workman, P. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.1.3 · Cited by 531
Peruzzi, F., Prisco, M., Dews, M., Salomoni, P., Grassilli, E., Romano, G., Calabretta, B., & Baserga, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7203 · Cited by 498
Multiple components in an epidermal growth factor-stimulated protein kinase cascade
Ahn, N. G., Seger, R., Bratlien, R. L., Diltz, C. D., Tonks, N. K., & Krebs, E. G. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64310-1 · Cited by 492
Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.
Rapp, U. R., Goldsborough, M. D., Mark, G. E., Bonner, T. I., Groffen, J., Reynolds, F. H., & Stephenson, J. R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4218 · Cited by 483
Marshall, C. J. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80066-4 · Cited by 462
Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation
Mason, C. S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2137 · Cited by 457
Raf proteins and cancer: B-Raf is identified as a mutational target
Mercer, K. E., & Pritchard, C. A. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00016-7 · Cited by 457
Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases
Marais, R., Light, Y., Paterson, H. F., Mason, C. S., & Marshall, C. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4378 · Cited by 456
Cdc25A is a novel phosphatase functioning early in the cell cycle.
Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H., & Okayama, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06417.x · Cited by 452
Cell cycle regulation by the Cdc25 phosphatase family
Nilsson, I., & Hoffmann, I. (2000) · Progress in Cell Cycle Research · doi:10.1007/978-1-4615-4253-7_10 · Cited by 450
Monia, B. P., Johnston, J. F., Geiger, T., Muller, M., & Fabbro, D. (1996) · Nature Medicine · doi:10.1038/nm0696-668 · Cited by 447
Pharmacological inhibitors of MAPK pathways
English, J. M., & Cobb, M. H. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01865-4 · Cited by 447
The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338
King, A. J., Sun, H., Diaz, B., Barnard, D., Miao, W., Bagrodia, S., & Marshall, M. S. (1998) · Nature · doi:10.1038/24184 · Cited by 443
Requirement of Ras-GTP-Raf Complexes for Activation of Raf-1 by Protein Kinase C
Marais, R., Light, Y., Mason, C., Paterson, H., Olson, M. F., & Marshall, C. J. (1998) · Science · doi:10.1126/science.280.5360.109 · Cited by 441
Discovery of a novel Raf kinase inhibitor.
Lyons, J. F., Wilhelm, S., Hibner, B., & Bollag, G. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080219 · Cited by 416
Mechanisms of regulating the Raf kinase family
Chong, H., Vikis, H. G., & Guan, K.-L. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00139-0 · Cited by 405
Yuen, S. T., Davies, H. R., Chan, T. L., Ho, J. W. C., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Tsui, W. W., Chan, A. S. Y., et al. (2002) · PubMed · Cited by 404
Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).
Chang, F., Steelman, L. S., Shelton, J. G., Lee, J. T., Navolanic, P. M., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · PubMed · Cited by 392
Ras Activation of the Raf Kinase: Tyrosine Kinase Recruitment of the MAP Kinase Cascade
Avruch, J. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.127 · Cited by 391
Direct Demonstration of Geranylgeranylation and Farnesylation of Ki-Ras in Vivo
Rowell, C. A., Kowalczyk, J. J., Lewis, M. D., & Garcia, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14093 · Cited by 368
Modulation of p53, ErbB1, ErbB2, and Raf-1 Expression in Lung Cancer Cells by Depsipeptide FR901228
Yu, X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.504 · Cited by 360
Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase.
Fabian, J. R., Daar, I. O., & Morrison, D. K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.7170 · Cited by 353
The Ras signal transduction pathway
Khosravi-Far, R., & Der, C. J. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00690419 · Cited by 348
Escudier, B., Szczylik, C., Eisen, T., Stadler, W. M., Schwartz, B., Shan, M., & Bukowski, R. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.lba4510 · Cited by 348
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
Tannapfel, A., Sommerer, F., Benicke, M., Katalinic, A., Uhlmann, D., Witzigmann, H., Hauss, J., & Wittekind, C. (2003) · Gut · doi:10.1136/gut.52.5.706 · Cited by 343
Role of Raf in Vascular Protection from Distinct Apoptotic Stimuli
Alavi, A., Hood, J. D., Frausto, R., Stupack, D. G., & Cheresh, D. A. (2003) · Science · doi:10.1126/science.1082015 · Cited by 336
Identification of the major phosphorylation sites of the Raf-1 kinase
Morrison, D. K., Heidecker, G., Rapp, U. R., & Copeland, T. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85336-x · Cited by 328
Phosphorylation of Raf by ceramide-activated protein kinase
Yao, B., Zhang, Y., Delikat, S., Mathias, S., Basu, S., & Kolesnick, R. (1995) · Nature · doi:10.1038/378307a0 · Cited by 327
Busca, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.12.2900 · Cited by 326
THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICS
Gibbs, J. B., & Oliff, A. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.143 · Cited by 324
Activation of the Raf-1 kinase cascade by coumermycin-induced dimerization
Farrar, M. A., Alberola-lla, J., & Perlmutter, R. M. (1996) · Nature · doi:10.1038/383178a0 · Cited by 318
Chen, J., Fujii, K., Zhang, L., Roberts, T., & Fu, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141224398 · Cited by 316
Active Ras induces heterodimerization of cRaf and BRaf.
Weber, C., Slupsky, J. R., Kalmes, H. A., & Rapp, U. R. (2001) · PubMed · Cited by 312
Mechanism of inhibition of Raf-1 by protein kinase A
Häfner, S., Adler, H. S., Mischak, H., Janosch, P., Heidecker, G., Wolfman, A., Pippig, S., Lohse, M., Ueffing, M., & Kolch, W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6696 · Cited by 312
Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene
Mikula, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1952 · Cited by 311
MEK kinase activity is not necessary for Raf-1 function
Huser, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1940 · Cited by 310
Signaling by dual specificity kinases
Dhanasekaran, N., & Reddy, E. P. (1998) · Oncogene · doi:10.1038/sj.onc.1202251 · Cited by 301
Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma.
Oka, H., Chatani, Y., Hoshino, R., Ogawa, O., Kakehi, Y., Terachi, T., Okada, Y., Kawaichi, M., Kohno, M., & Yoshida, O. (1995) · PubMed · Cited by 299
Wilhelm, S., & Chien, D.-S. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023393026 · Cited by 289
Voice, J. K., Klemke, R. L., Le, A., & Jackson, J. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17164 · Cited by 288
Regulation of MAP kinase activity by peptide receptor signalling pathway: Paradigms of multiplicity
Liebmann, C. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00192-9 · Cited by 287
Negative Regulation of the Serine/Threonine Kinase B-Raf by Akt
Guan, K.-L., Figueroa, C., Brtva, T. R., Zhu, T., Taylor, J., Barber, T. D., & Vojtek, A. B. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61518-8 · Cited by 281
Regulation of Raf-1 activation and signalling by dephosphorylation
Dhillon, A. S. (2002) · The EMBO Journal · doi:10.1093/emboj/21.1.64 · Cited by 280
Isotype-Specific Functions of Raf Kinases
Hagemann, C., & Rapp, U. R. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4689 · Cited by 261
Cell cycle targets of Ras/Raf signalling
Kerkhoff, E., & Rapp, U. R. (1998) · Oncogene · doi:10.1038/sj.onc.1202185 · Cited by 260
Takayama, T., Ohi, M., Hayashi, T., Miyanishi, K., Nobuoka, A., Nakajima, T., Satoh, T., Takimoto, R., Kato, J., Sakamaki, S., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.27203 · Cited by 257
Positive and negative regulation of Raf kinase activity and function by phosphorylation
Chong, H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.14.3716 · Cited by 255
Two Distinct Raf Domains Mediate Interaction with Ras
Brtva, T. R., Drugan, J. K., Ghosh, S., Terrell, R. S., Campbell-Burk, S., Bell, R. M., & Der, C. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9809 · Cited by 247
Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601
Zhang, B.-H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.20.5429 · Cited by 245
Mutational activation of c-raf-1 and definition of the minimal transforming sequence.
Heidecker, G., Huleihel, M., Cleveland, J. L., Kolch, W., Beck, T. W., Lloyd, P., Pawson, T., & Rapp, U. R. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.6.2503 · Cited by 240
Oligomerization activates c-Raf-1 through a Ras-dependent mechanism
Luo, Z., Tzivion, G., Belshaw, P. J., Vavvas, D., Marshall, M., & Avruch, J. (1996) · Nature · doi:10.1038/383181a0 · Cited by 237
KSR: a MAPK scaffold of the Ras pathway?
Morrison, D. K. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.9.1609 · Cited by 233
Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation.
Galaktionov, K., Jessus, C., & Beach, D. (1995) · Genes & Development · doi:10.1101/gad.9.9.1046 · Cited by 232
Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase.
Hg, W., Miyashita, T., Takayama, S.-I. J., Sato, T., Torigoe, T., Krajewski, S., Tanaka, S., Hovey, L., Troppmair, J., & Rapp, U. R. (1994) · PubMed · Cited by 229
Clinical Development of 17-Allylamino, 17-Demethoxygeldanamycin
Sausville, E., Tomaszewski, J., & Ivy, P. (2003) · Current Cancer Drug Targets · doi:10.2174/1568009033481831 · Cited by 225
Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338
Chaudhary, A., King, W. G., Mattaliano, M. D., Frost, J. A., Diaz, B., Morrison, D. K., Cobb, M. H., Marshall, M. S., & Brugge, J. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00475-9 · Cited by 225
Pritchard, C. A., Samuels, M. L., Bosch, E., & McMahon, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6430 · Cited by 224
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma
Gemignani, M. L., Schlaerth, A. C., Bogomolniy, F., Barakat, R. R., Lin, O., Soslow, R., Venkatraman, E., & Boyd, J. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00264-6 · Cited by 213
The discovery of potent cRaf1 kinase inhibitors
Lackey, K., Cory, M., Davis, R., Frye, S. V., Harris, P. A., Hunter, R. N., Jung, D. K., McDonald, O. B., McNutt, R. W., Peel, M. R., et al. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00668-x · Cited by 206
Diaz, B., Barnard, D., Filson, A., MacDonald, S., King, A., & Marshall, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4509 · Cited by 203
Li, S., & Sedivy, J. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9247 · Cited by 202
Houslay, M. D., & Kolch, W. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23096-0 · Cited by 202
[40] Biological assays for Ras transformation
Clark, G. J., Cox, A. D., Graham, S. M., & Der, C. J. (1995) · Methods in Enzymology · doi:10.1016/s0076-6879(95)55042-9 · Cited by 198
Catling, A. D., Schaeffer, H.-J., Reuter, C. W. M., Reddy, G. R., & Weber, M. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5214 · Cited by 196
Structure and biological activity of human homologs of the raf/mil oncogene.
Bonner, T. I., Kerby, S. B., Sutrave, P., Gunnell, M. A., Mark, G., & Rapp, U. R. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.6.1400 · Cited by 193
Increasing Complexity of Ras Signal Transduction: Involvement of Rho Family Proteins
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60700-9 · Cited by 184
Chuang, E., Barnard, D., Hettich, L., Zhang, X. F., Avruch, J., & Marshall, M. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5318 · Cited by 184
Raf induces NF-κB by membrane shuttle kinase MEKK1, a signaling pathway critical for transformation
Baumann, B., Weber, C. K., Troppmair, J., Whiteside, S., Israel, A., Rapp, U. R., & Wirth, T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080583397 · Cited by 177
Ras effectors and their role in mitogenesis and oncogenesis
Joneson, T., & Bar-Sagi, D. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050143 · Cited by 167
The Mouse B-raf Gene Encodes Multiple Protein Isoforms with Tissue-specific Expression
Barnier, J. V., Papin, C., Eychène, A., Lecoq, O., & Calothy, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23381 · Cited by 166
KSR stimulates Raf-1 activity in a kinase-independent manner
Michaud, N. R., Therrien, M., Cacace, A., Edsall, L. C., Spiegel, S., Rubin, G. M., & Morrison, D. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.12792 · Cited by 166
Gene Expression Patterns in Ependymomas Correlate with Tumor Location, Grade, and Patient Age
Korshunov, A., Neben, K., Wrobel, G., Tews, B., Benner, A., Hahn, M., Golanov, A., & Lichter, P. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63530-4 · Cited by 161
Schaap, D., van der Wal, J., Howe, L. R., Marshall, C. J., & van Blitterswijk, W. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80719-4 · Cited by 160
A genome-based strategy uncovers frequent BRAF mutations in melanoma
Pollock, P. M., & Meltzer, P. S. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00089-2 · Cited by 160
Pritchard, C. A., Bolin, L., Slattery, R., Murray, R., & McMahon, M. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00548-1 · Cited by 159
Yan, M., & Templeton, D. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32275-5 · Cited by 158
Regulation of Raf by Akt Controls Growth and Differentiation in Vascular Smooth Muscle Cells
Reusch, H. P., Zimmermann, S., Schaefer, M., Paul, M., & Moelling, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105322200 · Cited by 158
Dephosphorylation of Ser-259 Regulates Raf-1 Membrane Association
Kubicek, M., Pacher, M., Abraham, D., Podar, K., Eulitz, M., & Baccarini, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108733200 · Cited by 154
Activation of Raf by ionizing radiation
Kasid, U. N., Suy, S., Dent, P., Ray, S., Whiteside, T. L., & Sturgill, T. W. (1996) · Nature · doi:10.1038/382813a0 · Cited by 153
Effect of SB 203580 on the activity of c-Raf in vitro and in vivo
Hall-Jackson, C. A., Goedert, M., Hedge, P., & Cohen, P. (1999) · Oncogene · doi:10.1038/sj.onc.1202603 · Cited by 151
The raf Oncogene Is Associated with a Radiation-Resistant Human Laryngeal Cancer
Kasid, U. N., Pfeifer, A., Weichselbaum, R. R., Dritschilo, A., & Mark, G. E. (1987) · Science · doi:10.1126/science.3616625 · Cited by 145
Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis
Wojnowski, L., Stancato, L. F., Larner, A. C., Rapp, U. R., & Zimmer, A. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00276-2 · Cited by 143
Sun, H., King, A. J., Diaz, H. B., & Marshall, M. S. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00359-6 · Cited by 141
Jaiswal, R. K., Moodie, S. A., Wolfman, A., & Landreth, G. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6944 · Cited by 140
Ras Interaction with Two Distinct Binding Domains in Raf-1 5 Be Required for Ras Transformation
Drugan, J. K., Khosravi‐Far, R., White, M. A., Der, C. J., Sung, Y., Hwang, Y., & Campbell, S. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.233 · Cited by 136
Monia, B. P., Sasmor, H. M., Johnston, J. F., Freier, S. M., Lesnik, E. A., Muller, M., Geiger, T. M., Altmann, K., Moser, H. E., & Fabbro, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15481 · Cited by 136
BRAF and KRAS mutations in stomach cancer
Lee, S. H., Lee, J. W., Soung, Y. H., Kim, H. S., Park, W. S., Kim, S. Y., Lee, J., Park, J. Y., Cho, Y. G., Kim, C. J., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206749 · Cited by 135
Lack of BRAF Mutation in Primary Uveal Melanoma
Cohen, Y., Goldenberg‐Cohen, N., Parrella, P., Chowers, I., Merbs, S. L., Pe’er, J., & Sidransky, D. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1329 · Cited by 135
Randomized discontinuation trials: Utility and efficiency
Kopec, J. A., Abrahamowicz, M., & Esdaile, J. M. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90163-u · Cited by 134
Mutations of the BRAF gene in squamous cell carcinoma of the head and neck
Weber, A., Langhanki, L., Sommerer, F., Markwarth, A., Wittekind, C., & Tannapfel, A. (2003) · Oncogene · doi:10.1038/sj.onc.1206705 · Cited by 131
Rudin, C. M., Holmlund, J. T., Fleming, G. F., Mani, S., Stadler, W. M., Schumm, L. P., Monia, B. P., Johnston, J. F., Geary, R. S., Yu, R. Z., et al. (2001) · PubMed · Cited by 129
Stevenson, J. P., Yao, K.-S., Gallagher, M., Friedland, D. P., Mitchell, E. P., Cassella, A., Monia, B. P., Kwoh, T. J., Yu, R. Z., Holmlund, J., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2227 · Cited by 129
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt.
Majewski, M., Nieborowska-Skorska, M., Salomoni, P., Słupianek, A., Reiss, K., Trotta, R., Calabretta, B., & Skórski, T. (1999) · PubMed · Cited by 126
Cunningham, C. C., Holmlund, J., Schiller, J. H., Geary, R. S., Kwoh, T. J., Dorr, A., & Nemunaitis, J. J. (2000) · PubMed · Cited by 126
Wu, X., Noh, S. J., Zhou, G., Dixon, J. E., & Guan, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3265 · Cited by 119
Tolcher, A. W., Reyno, L. M., Venner, P. M., Ernst, S., Moore, M. J., Geary, R. S., Chi, K., Hall, S. R. R., Walsh, W., Dorr, A., et al. (2002) · PubMed · Cited by 119
Wang, S., Ghosh, R. N., & Chellappan, S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7487 · Cited by 118
Pharmacological inhibitors of the ERK signaling pathway: application as anticancer drugs.
Kohno, M., & Pouysségur, J. (2003) · PubMed · Cited by 115
Homologous cell-derived oncogenes in avian carcinoma virus MH2 and murine sarcoma virus 3611
Jansen, H. W., Lurz, R., Bister, K., Bonner, T. I., Mark, G. E., & Rapp, U. R. (1984) · Nature · doi:10.1038/307281a0 · Cited by 115
Associations of B- and C-Raf with Cholesterol, Phosphatidylserine, and Lipid Second Messengers
Hekman, M., Hamm, H., Villar, A. V., Bader, B., Kuhlmann, J., Nickel, J., & Rapp, U. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200576200 · Cited by 115
Biochemical Analysis of MEK Activation in NIH3T3 Fibroblasts
Reuter, C. W., Catling, A. D., Jelı́nek, T., & Weber, M. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7644 · Cited by 114
Cohen, M. S., Hussain, H. B., & Moley, J. F. (2002) · Surgery · doi:10.1067/msy.2002.128562 · Cited by 113
Stancato, L. F., Sakatsume, M., David, M., Dent, P., Dong, F., Petricoin, E. F., Krolewski, J. J., Silvennoinen, O., Saharinen, P., Pierce, J. H., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3833 · Cited by 112
Marshall, C. J. (1996) · Nature · doi:10.1038/383127a0 · Cited by 109
Cornwell, M. M., & Smith, D. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82262-1 · Cited by 107
Sutrave, P., Bonner, T. I., Rapp, U. R., Jansen, H. W., Patschinsky, T., & Bister, K. (1984) · Nature · doi:10.1038/309085a0 · Cited by 107
Kerkhoff, E., Fedorov, L. M., Siefken, R., Walter, A. O., Papadopoulos, T. G., & Rapp, U. R. (2000) · PubMed · Cited by 105
Strumberg, D., Voliotis, D., Moeller, J.-G., Hilger, R. A., Richly, H., Kredtke, S., Beling, C., Scheulen, M. E., & Seeber, S. (2002) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp40580 · Cited by 104
Serum- and Glucocorticoid-inducible Kinase SGK Phosphorylates and Negatively Regulates B-Raf
Zhang, B.-H., Tang, E., Zhu, T., Greenberg, M. E., Vojtek, A. B., & Guan, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102808200 · Cited by 103
Phillips, J. A., Craig, S. J., Bayley, D., Christian, R. A., Geary, R., & Nicklin, P. L. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00190-1 · Cited by 103
Yamamori, B., Kuroda, S., Shimizu, K., Fukui, K., Ohtsuka, T., & Takai, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.11723 · Cited by 99
Geary, R. S., Leeds, J. M., Fitchett, J. R., et al. (1997) · PubMed · Cited by 98
Cripps, M. C., Figueredo, A. T., Oza, A. M., Taylor, M. J., Fields, A. L. A., Holmlund, J. T., McIntosh, L., Geary, R. S., & Eisenhauer, E. A. (2002) · PubMed · Cited by 96
Activation of Human raf Transforming Genes by Deletion of Normal Amino-Terminal Coding Sequences
Stanton, V. P., & Cooper, G. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.3.1171 · Cited by 96
Iacovelli, L., Capobianco, L., Salvatore, L., Sallese, M., D'Ancona, G. M., & Blasi, A. D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12501-1 · Cited by 95
Jaiswal, R. K., Weissinger, E. M., Kölch, W., & Landreth, G. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23626 · Cited by 90
Coudert, B. P., Anthoney, A., Fiedler, W., Droz, J., Dieras, V. C., Borner, M., Smyth, J. F., Morant, R., de Vries, M. J., Roelvink, M., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00286-6 · Cited by 83
Prendergast, G. C., & Oliff, A. I. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0335 · Cited by 81
Okada, T., Hu, C., Jin, T. J., Kariya, K., Yamawaki‐Kataoka, Y., & Kataoka, T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6057 · Cited by 81
Nantel, A., Huber, M., & Thomas, D. Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35719 · Cited by 80
Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system.
Papin, C., DENOUEL, A., Calothy, G., & Eychène, A. (1996) · PubMed · Cited by 76
Oza, A. M., Elit, L. M., Swenerton, K., Faught, W., Ghatage, P., Carey, M., McIntosh, L., Dorr, A., Holmlund, J., & Eisenhauer, E. A. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(02)00144-0 · Cited by 75
Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma
Sommerer, F., Vieth, M. W., Markwarth, A., Röhrich, K., Vomschloß, S., May, A., Ell, C., Stolte, M., Hengge, U. R., Wittekind, C., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207189 · Cited by 69
A Common onc Gene Sequence Transduced by Avian Carcinoma Virus MH2 and by Murine Sarcoma Virus 3611
Kan, N. C., Flordellis, C. S., Mark, G. E., DUESBERG, P. H., & Papas, T. S. (1984) · Science · doi:10.1126/science.6320371 · Cited by 69
BRAF mutations in non-Hodgkin's lymphoma
Lee, J. W., Yoo, N. J., Soung, Y. H., Kim, H. S., Park, W. S., Kim, S. Y., Lee, J. H., Park, J. Y., Cho, Y. G., Kim, C. J., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601371 · Cited by 68
Antisense technology for cancer therapy: does it make sense?
Carter, G., & Lemoine, N. R. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.164 · Cited by 66
Differential Expression and Mutation of therasFamily Genes in Human Breast Cancer
Miyakis, S., Sourvinos, G., & Spandidos, D. A. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9527 · Cited by 65
The Raf‐1 kinase associates with vimentin kinases and regulates the structure of vimentin filaments
Janosch, P., Kieser, A., Eulitz, M., Lovrić, J., Sauer, G., Reichert, M., Gounari, F., Büscher, D., Baccarini, M., Mischak, H., et al. (2000) · The FASEB Journal · doi:10.1096/fj.99-0883com · Cited by 65
Isoform-Specific Localization of A-RAF in Mitochondria
Yuryev, A., Ono, M., Goff, S. A., Macaluso, F., & Wennogle, L. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4870-4878.2000 · Cited by 64
Yamashita, N., Minamoto, T., Ochiai, A., Onda, M., & Esumi, H. (1995) · Cancer · Cited by 61
Jamal, S., & Ziff, E. B. (1995) · PubMed · Cited by 59
Morice, C., Nothias, F., König, S., et al. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00609.x · Cited by 57
Activation of c-Raf Kinase by Ultraviolet Light
Hoyos, B., Imam, A., Korichneva, I., Levi, E., Chua, R., & Hammerling, U. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110750200 · Cited by 55
Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors
Storm, S. M., & Rapp, U. R. (1993) · Toxicology Letters · doi:10.1016/0378-4274(93)90056-4 · Cited by 53
Dhillon, A. S., Meikle, S., Peyssonnaux, C., Grindlay, J., Kaiser, C., Steen, H., Shaw, P. E., Mischak, H., Eychène, A., & Kölch, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.1983-1993.2003 · Cited by 51
Antisense raf Oligodeoxyribonucleotide Is a Radiosensitizer In Vivo
Gokhale, P. C., McRae, D. A., Monia, B. P., Bagg, A., RAHMAN, A., Dritschilo, A., & Kasid, U. N. (1999) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1999.9.191 · Cited by 50
Shelton, J. G., Moye, P. W., Steelman, L. S., Blalock, W. L., Lee, J. T., Franklin, R. A., McMahon, M., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2403052 · Cited by 49
Synthesis and Antitumor Activity of Novel O-Carbamoylmethyloxime Derivatives of Radicicol
Ikuina, Y., Amishiro, N., Miyata, M., Narumi, H., Ogawa, H., Akiyama, T., Shiotsu, Y., Akinaga, S., & Murakata, C. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030110r · Cited by 48
Henry, S. P., Monteith, D. K. B., Bennett, F., et al. (1997) · PubMed · Cited by 48
Patterns of proto‐oncogene expression in human glioma cell lines
Larocca, R. V., Rosenblum, M. L., Westermark, B., & Israel, M. A. (1989) · Journal of Neuroscience Research · doi:10.1002/jnr.490240114 · Cited by 39
ras Proto-Oncogene Activation in Human Malignancy
Clark, G. J., & Der, C. J. (1995) · Humana Press eBooks · doi:10.1007/978-1-4757-2381-6_2 · Cited by 39
Involvement of the RAFI locus, at band 3p25, in the 3p deletion of small‐cell lung cancer
Graziano, S. L., Pfeifer, A. M. A., Testa, J. R., Mark, G. E., Johnson, B. E., Hallinan, E. J., Pettengill, O. S., Sorenson, G. D., Tatum, A. H., Brauch, H. B., et al. (1991) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870030407 · Cited by 37
Campbell, S. L., Otis, M., Côté, M., Gallo‐Payet, N., & PAYET, M. D. (2003) · Endocrinology · doi:10.1210/en.2002-220903 · Cited by 33
Heim, M. H., Sharifi, M., Hilger, R. A., Scheulen, M. E., Seeber, S., & Strumberg, D. (2003) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp41616 · Cited by 33
Molecular Cloning and Characterization of an Activated Human c-raf-1 Gene
Fukui, M., Yamamoto, T. S., Kawai, S., Mitsunobu, F., & Toyoshima, K. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1776 · Cited by 32
Richly, H., Kupsch, P., Passage, K. J., Grubert, M., Hilger, R. A., Kredtke, S., Voliotis, D., Scheulen, M. E., Seeber, S., & Strumberg, D. (2003) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp41620 · Cited by 28
Interactions between p21ras proteins and their GTPase activating proteins.
Polakis, P. G., & McCormick, F. P. (1992) · PubMed · Cited by 27
Activation of Raf-1 in Human Pancreatic Adenocarcinoma
Berger, D. H., Jardines, L. A., Chang, H., & Ruggeri, B. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1997.5022 · Cited by 21
Patriotis, C., Russeva, M., Lin, J., Srinivasula, S. M., Markova, D., Tsatsanis, C., Makris, A. M., Alnemri, E. S., & Tsichlis, P. N. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.1066 · Cited by 18
McFarlin, D. R. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg045 · Cited by 12
Cited by
Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
Santarpia, L., Lippman, S. M., & El-Naggar, A. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645805 · Cited by 1,027
Broad targeting of resistance to apoptosis in cancer
Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.-Y., Lin, L.-T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.001 · Cited by 864
NCCN Guidelines Insights: Colon Cancer, Version 2.2018
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0021 · Cited by 806
Haroche, J., Charlotte, F., Arnaud, L., von Deimling, A., Hélias-Rodzewicz, Z., Hervier, B., Cohen-Aubart, F., Launay, D., Lesot, A., Mokhtari, K., et al. (2012) · Blood · doi:10.1182/blood-2012-05-430140 · Cited by 696
Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Schmidinger, M., Zielinski, C. C., Vogl, U. M., Bojic, A., Bojic, M., Schukro, C., Ruhsam, M., Hejna, M., & Schmidinger, H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6331 · Cited by 615
Metadata
- Authors
- Beeram, M., Patnaik, A., & Rowinsky, E. K.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-09-20
- Volume
- 23
- Issue
- 27
- Pages
- 6771-6790
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2010890298
- Cited by
- 298
- References
- 197
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.